Safety profile of 0.0015% tafluprost eye drops in China: a post-marketing observational study.
Sign Up to like & getrecommendations! Published in 2023 at "International journal of ophthalmology"
DOI: 10.18240/ijo.2023.01.16
Abstract: AIM To investigate the treatment pattern and safety of tafluprost for glaucoma and ocular hypertension (OH) in clinical practice in China. METHODS This post-marketing observational study included patients who received tafluprost to lower intraocular pressure… read more here.
Keywords: marketing observational; eye drops; post marketing; tafluprost ... See more keywords